You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API pemetrexed


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing pemetrexed

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Hospira Inc PEMETREXED pemetrexed 0409-0020 MONOTHIOGLYCEROL
Hospira Inc PEMETREXED pemetrexed 0409-0020 SODIUM HYDROXIDE
Hospira Inc PEMETREXED pemetrexed 0409-0020 WATER
Hospira Inc PEMETREXED pemetrexed 0409-1045 MONOTHIOGLYCEROL
Hospira Inc PEMETREXED pemetrexed 0409-1045 SODIUM HYDROXIDE
Hospira Inc PEMETREXED pemetrexed 0409-1045 WATER
Hospira Inc PEMETREXED pemetrexed 0409-1060 MANNITOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing pemetrexed

Company Ingredient NDC Excipient
Baxter Healthcare Corporation pemetrexed 0338-0720 HYDROCHLORIC ACID
Baxter Healthcare Corporation pemetrexed 0338-0720 MANNITOL
Baxter Healthcare Corporation pemetrexed 0338-0720 SODIUM HYDROXIDE
Accord Healthcare Inc pemetrexed 16729-229 HYDROCHLORIC ACID
Accord Healthcare Inc pemetrexed 16729-229 MANNITOL
Accord Healthcare Inc pemetrexed 16729-229 SODIUM HYDROXIDE
Solco Healthcare US LLC pemetrexed 43547-632 HYDROCHLORIC ACID
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for pemetrexed

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: CYSTEINE HYDROCHLORIDE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: MANNITOL

Excipient focus: METHIONINE

Excipient focus: MONOTHIOGLYCEROL

Excipient focus: NITROGEN

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM THIOSULFATE

Excipient focus: TROMETHAMINE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group